-
1Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia [electronic resource] : Proce... Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia [electronic resource] : Proce...Texto bibliotecaCOLPOS
-
2Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia [electronic resource] : Proce... Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia [electronic resource] : Proce...Texto bibliotecaCOLPOS
-
3Congestive Heart Failure [electronic resource] : Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania / Congestive Heart Failure [electronic resource] : Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania /Texto bibliotecaCOLPOS
-
4
-
5Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic resource] : Proceedings of the Ninth Annual Symposium on New Dr... Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic resource] : Proceedings of the Ninth Annual Symposium on New Dr...Texto bibliotecaCOLPOS
-
6
-
7Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic resource] : Proceedings of the Ninth Annual Symposium on New Dr... Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic resource] : Proceedings of the Ninth Annual Symposium on New Dr...Texto bibliotecaCOLPOS